Review





Similar Products

99
ATCC crl 8303 bsl 1 caf
Crl 8303 Bsl 1 Caf, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crl 8303 bsl 1 caf/product/ATCC
Average 99 stars, based on 1 article reviews
crl 8303 bsl 1 caf - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti chaf1b
Anti Chaf1b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti chaf1b/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti chaf1b - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti chaf1a
Mouse Monoclonal Anti Chaf1a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti chaf1a/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mouse monoclonal anti chaf1a - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Crystran Ltd petri dish with a caf 2 bottom cafp22-1
Petri Dish With A Caf 2 Bottom Cafp22 1, supplied by Crystran Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/petri dish with a caf 2 bottom cafp22-1/product/Crystran Ltd
Average 90 stars, based on 1 article reviews
petri dish with a caf 2 bottom cafp22-1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

96
Proteintech myo
Myo, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myo/product/Proteintech
Average 96 stars, based on 1 article reviews
myo - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology caf 1 p150
Figure 6. Metformin and CAF-1. (A) Western blots for CAF-1 major subunits, <t>p150</t> and p60, of CAL27 treated with metformin for 24, 48 and 72 hours. (B) CAF-1 silencing by siRNAs in CAL27 assessed via WB. (C) Wound healing assay of CAL27 silenced for CAF-1/p150 and CAF-1/p60. (D) Invasion assay of CAF-1 silenced CAL27. (E) Immunofluorescence of E- and N-cadherin of CAL27 silenced for CAF-1 major subunits (scale bar = 20 μm). (F) Western blots for CAF-1 major subunits, p150 and p60, of SCC154 treated with metformin for 24, 48 and 72 hours. (G) CAF-1 silencing by siRNAs in SCC154 assessed via WB. (H) Wound healing assay of SCC154 silenced for CAF-1/p150 and CAF-1/p60. (I) Invasion assay of CAF-1 silenced SCC154. (J) Immunofluorescence of E- and N-cadherin of SCC154 silenced for CAF-1 major subunits (scale bar = 20 μm). Significant differences from control conditions are indicated by asterisks (* p ≤ 0,05; ** p ≤ 0,01).
Caf 1 P150, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caf 1 p150/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
caf 1 p150 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

99
ATCC fibroblasts cafs
Figure 6. Metformin and CAF-1. (A) Western blots for CAF-1 major subunits, <t>p150</t> and p60, of CAL27 treated with metformin for 24, 48 and 72 hours. (B) CAF-1 silencing by siRNAs in CAL27 assessed via WB. (C) Wound healing assay of CAL27 silenced for CAF-1/p150 and CAF-1/p60. (D) Invasion assay of CAF-1 silenced CAL27. (E) Immunofluorescence of E- and N-cadherin of CAL27 silenced for CAF-1 major subunits (scale bar = 20 μm). (F) Western blots for CAF-1 major subunits, p150 and p60, of SCC154 treated with metformin for 24, 48 and 72 hours. (G) CAF-1 silencing by siRNAs in SCC154 assessed via WB. (H) Wound healing assay of SCC154 silenced for CAF-1/p150 and CAF-1/p60. (I) Invasion assay of CAF-1 silenced SCC154. (J) Immunofluorescence of E- and N-cadherin of SCC154 silenced for CAF-1 major subunits (scale bar = 20 μm). Significant differences from control conditions are indicated by asterisks (* p ≤ 0,05; ** p ≤ 0,01).
Fibroblasts Cafs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibroblasts cafs/product/ATCC
Average 99 stars, based on 1 article reviews
fibroblasts cafs - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Metformin and CAF-1. (A) Western blots for CAF-1 major subunits, p150 and p60, of CAL27 treated with metformin for 24, 48 and 72 hours. (B) CAF-1 silencing by siRNAs in CAL27 assessed via WB. (C) Wound healing assay of CAL27 silenced for CAF-1/p150 and CAF-1/p60. (D) Invasion assay of CAF-1 silenced CAL27. (E) Immunofluorescence of E- and N-cadherin of CAL27 silenced for CAF-1 major subunits (scale bar = 20 μm). (F) Western blots for CAF-1 major subunits, p150 and p60, of SCC154 treated with metformin for 24, 48 and 72 hours. (G) CAF-1 silencing by siRNAs in SCC154 assessed via WB. (H) Wound healing assay of SCC154 silenced for CAF-1/p150 and CAF-1/p60. (I) Invasion assay of CAF-1 silenced SCC154. (J) Immunofluorescence of E- and N-cadherin of SCC154 silenced for CAF-1 major subunits (scale bar = 20 μm). Significant differences from control conditions are indicated by asterisks (* p ≤ 0,05; ** p ≤ 0,01).

Journal: Pathologica

Article Title: Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1

doi: 10.32074/1591-951x-1085

Figure Lengend Snippet: Figure 6. Metformin and CAF-1. (A) Western blots for CAF-1 major subunits, p150 and p60, of CAL27 treated with metformin for 24, 48 and 72 hours. (B) CAF-1 silencing by siRNAs in CAL27 assessed via WB. (C) Wound healing assay of CAL27 silenced for CAF-1/p150 and CAF-1/p60. (D) Invasion assay of CAF-1 silenced CAL27. (E) Immunofluorescence of E- and N-cadherin of CAL27 silenced for CAF-1 major subunits (scale bar = 20 μm). (F) Western blots for CAF-1 major subunits, p150 and p60, of SCC154 treated with metformin for 24, 48 and 72 hours. (G) CAF-1 silencing by siRNAs in SCC154 assessed via WB. (H) Wound healing assay of SCC154 silenced for CAF-1/p150 and CAF-1/p60. (I) Invasion assay of CAF-1 silenced SCC154. (J) Immunofluorescence of E- and N-cadherin of SCC154 silenced for CAF-1 major subunits (scale bar = 20 μm). Significant differences from control conditions are indicated by asterisks (* p ≤ 0,05; ** p ≤ 0,01).

Article Snippet: Primary antibodies anti-CHAF1B (rabbit polyclonal HPA021679; Sigma-Aldrich, St. Louis, MO, USA); CAF-1 p150 (mouse monoclonal sc-32742; Santa Cruz, Dallas, TX, USA); GAPDH (rabbit monoclonal, (14C10) #2118; Cell Signaling Technology, Danvers, MA, USA) were used overnight at 4°C.

Techniques: Western Blot, Wound Healing Assay, Invasion Assay, Immunofluorescence, Control